Japan's Taisho Establishes Global OTC Footprint With $1.6bn Acquisition of Bristol-Myers Squibb's UPSA

 
• By Tom Gallen
  
HBW1812_Network Map_1091222291_1200.jpg
Taisho is building a global consumer health operation with UPSA • Source: Shutterstock

More from Deals

More from Business